SWISSMEMBRANE
Live / Applied — Suspended — suspension letter mailed (as of 25 Sept 2025)
What this means for you
Not registered yet, but its 21 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98865916
- Mark type
- Stylized text
- Filed
- 21 Nov 2024
- Attorney of record
- George R. Repper
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations and substances for treating skin disorders, tooth loss, trauma or tumor resection, bone defect or loss, cartilage defects, chondral and osteochondral lesions, meniscal lesions, diabetes; hemostatic products, namely, dental hemostatic paste, medical hemostatic paste, hemostatic pencils; wound dressing material, namely, hemostatic gel matrix preparations for treating wounds, pharmaceutical preparations for treating wounds, liquid bandages for skin wounds; vulnerary sponges; tissue adhesives for medical purposes, namely, medical adhesives for binding internal tissue, medical adhesives tapes for binding wounds; filling and implant materials of natural origin for dental, maxillofacial and orthopedic surgery, especially for the regeneration of soft tissue, namely skin grafts, processed human donor skin for the replacement of soft tissue; medical plasters and medical dressings; collagen for medical purposes, namely, biocompatible collagen-material, in particular biocompatible collagen-membranes, biocompatible collagen-matrixes or biocompatible collagen-sponge for use in dental, maxillofacial and orthopedic surgery, especially for the regeneration of soft tissue, or for use as a hemostatic agent in surgery
- Class 010 — Medical apparatus: Surgical, medical, dental and veterinary apparatus and instruments for use in orthopedic surgery, oral surgery, maxillofacial surgery; biocompatible collagen-material, in particular biocompatible collagen-membranes, biocompatible collagen-matrixes or biocompatible collagen-sponge, namely, collagen barrier membranes for oral, maxillofacial and orthopedic surgical procedures, especially for the regeneration of soft tissue, or for use as a hemostatic agent in surgery; surgical implants and surgical sponges comprised of synthetic collagen materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies
Owner
- Geistlich Pharma AG, Wolhusen, CH
Prosecution history
- 25 Sept 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 25 Sept 2025 — LETTER OF SUSPENSION E-MAILED
- 25 Sept 2025 — SUSPENSION LETTER WRITTEN
- 08 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 May 2025 — NON-FINAL ACTION E-MAILED
- 16 May 2025 — NON-FINAL ACTION WRITTEN
- 15 May 2025 — ASSIGNED TO EXAMINER
- 26 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Nov 2024 — APPLICATION FILING RECEIPT MAILED
- 21 Nov 2024 — NEW APPLICATION ENTERED